Abstract
Patients infected with carbapenem-resistant Enterobacteriaceae often experience delays in initiation of appropriate antimicrobial therapy and increased mortality. A score was developed to differentiate bloodstream infections caused by carbapenem-resistant Enterobacteriaceae (16 patients) versus extended-spectrum β-lactamase-producing Enterobacteriaceae (166 patients). A score of ≥32 demonstrated high area under the curve of 0.80 (95% confidence interval: 0.68-0.92) and a negative predictive value of 97%.
Original language | English |
---|---|
Pages (from-to) | 180-182 |
Number of pages | 3 |
Journal | American Journal of Infection Control |
Volume | 41 |
Issue number | 2 |
DOIs | |
State | Published - Feb 2013 |
Externally published | Yes |
Keywords
- CRE
- Carbapenem-resistant Enterobacteriaceae
- Colistin
- ESBL
- Extended-spectrum β-lactamase
- Klebsiella pneumoniae carbapenemase
- Time to effective therapy